
18 December 2025Publication
EU regulatory shifts for HLS in 2026
2026 will see several important legislative reforms and new initiatives that are expected to shape the sector’s operations and strategic priorities.
The consumer health sector might be slightly less regulated than classic therapeutical products as less active pharmaceutical ingredients (API) are processed, however the industry is still facing serious issues.
Over The Counter products (OTCs) do not require a physician’s prescription. This means they are delivered through pharmacies and sold in drugstores, supermarkets and other retail outlets. They are manufactured in large volumes. Typical consumer health products fall into the categories of pain relief, oral health, nutrition/gastro-intestinal, skin health and respiratory. And they are required to meet strict industrial and logistics criteria’s.
But despite their soft therapeutical action, OTCs are still under scrutiny by the health authorities.
We work with our clients to help them address a broad range of issues. From those arising through the product development phase to the manufacturing, distribution and marketing challenges. Whatever aspect you’re seeking advice on, we’re confident we can help.
Our teams across international regulatory, market access, corporate, commercial and IP support our clients worldwide. From a products (inter)national launch and compliance procedures to product liability and pharmacovigilance.
Assisting Procter & Gamble Pharmaceuticals in setting up and negotiating clinical trial agreements for a large multi-centre clinical study involving over 100 centres in 13 European countries.
Advising Reckitt Benckiser Healthcare on the distribution of one of its medicines in continental Europe. This included drafting and reviewing distribution and logistics agreements and advising on pharma-covigilance and related regulatory aspects.
If you have any questions, contact a member of the Consumer Health team for assistance:

18 December 2025Publication
2026 will see several important legislative reforms and new initiatives that are expected to shape the sector’s operations and strategic priorities.
17 April 2023 Publication
The online terms and conditions of Camelot, the National Lottery provider, have proved effective in defeating a claim by a player who thought she had won £1m.
16 January 2023 Publication
The Court of Justice of the European Union has ruled that a Latvian law restricting advertising of medicinal products complies with EU law.

09 May 2022 Publication
From 28 March 2022 to 20 June 2022, the European Commission is organising a public consultation in view of the revision of the regulation on cosmetic products.
24 June 2021 Publication
Following the controversial Health Data Law, the UAE Federal Government has added another piece to the health data protection regime in the form of the Decision